Skip to main content
. 2014 Aug 15;16(4):4225. doi: 10.1186/s13075-014-0411-6

Figure 4.

Figure 4

MMP-1, MMP-3, TIMP-1 and PAI-1 expression; MMP-1/TIMP-1 ratio; and MMP-1 activity in fibroblasts. (A) Matrix metalloproteinase 1 (MMP-1) released into cell culture media after platelet-derived growth factor (PDGF), dihydrolipoic acid (DHLA) and/or N-acetylcysteine (NAC) incubation. (B) MMP-3 released into cell culture media after PDGF, DHLA and/or NAC incubation. (C) Tissue inhibitor of matrix metalloproteinase 1 (TIMP-1) in cell culture media after PDGF, DHLA and/or NAC incubation. (D) The MMP-1/TIMP-1 ratio in normal (NL) and scleroderma (SSc) dermal fibroblasts. (E) MMP-1 activity was significantly higher in NL dermal fibroblasts than in SSc cells. PDGF significantly increased MMP-1 activity in NL and SSc cells. Both DHLA and NAC appeared to increase MMP-1 activity significantly in SSc dermal fibroblasts when stimulated by PDGF. (F) Plasminogen activator inhibitor 1 released from both NL and SSc dermal fibroblasts in the presence of PDGF, DHLA, and/or NAC. Results are expressed as mean ± SEM. P < 0.05 was considered significant. BM, Basal medium; NL, Normal; NS, Nonstimulated.